Key result
Human FcRn functions as a dual attachment and uncoating receptor for Echovirus 18.
Why the study?
Echovirus 18 causes clinical syndromes including aseptic meningitis with no approved antivirals or vaccines, and CD55 was found not to be its critical host factor, leaving its receptors and entry mechanism unknown.
Human FcRn serves as both the attachment and uncoating receptor for Echovirus 18, providing a potential target for future antiviral therapies.
Hypothesis-generating for FcRn as E18 antiviral target; leaves open translation to human disease or therapy.
E18 is a member of enterovirus species B. As one of the most common enterovirus serotypes in nonpolio enterovirus detection, it easily infects children and causes various clinical symptoms. Aseptic meningitis and viral encephalitis are the most commonly reported syndromes associated with E18. No effective antiviral drugs or approved vaccines are available. Previous studies showed that CD55 and FcRn were the binding and uncoating receptors for some echoviruses. However, we found that CD55 is not the critical host factor for E18. Thus, we want to determine the receptors and elucidate the entry mechanism of E18. Our findings reveal that FcRn is a two-in-one attachment-uncoating receptor for E18.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2022) studied Echovirus 18 infection. Human FcRn functions as a two-in-one attachment-uncoating receptor for Echovirus 18, while CD55 is not a critical host factor for viral entry.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: